AC
ALIM

Armistice Capital’s Alimera Sciences ALIM Stock Holding History

Armistice Capital’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-340,000
Closed -$2.58M – 104
2019
Q4 		$2.58M Sell
340,000
-55,733
-14% -$333K 0.15% 67
2019
Q3 		$3.36M Buy
395,733
+6,666
+2% +$60.6K 0.22% 56
2019
Q2 		$5.19M Sell
389,067
-73,333
-16% -$1.03M 0.33% 48
2019
Q1 		$7.35M Hold
462,400
– – 0.4% 47
2018
Q4 		$4.98M Hold
462,400
– – 0.38% 49
2018
Q3 		$6.8M Hold
462,400
– – 0.41% 53
2018
Q2 		$6.79M Hold
462,400
– – 0.44% 56
2018
Q1 		$7.14M Buy
462,400
+8,267
+2% +$147K 0.55% 48
2017
Q4 		$9.06M Buy
454,133
+36,533
+9% +$713K 0.9% 39
2017
Q3 		$8.46M Buy
417,600
+24,267
+6% +$519K 1% 39
2017
Q2 		$8.2M Buy
393,333
+97,600
+33% +$2.09M 1.05% 38
2017
Q1 		$6.21M Buy
295,733
+82,400
+39% +$1.59M 1.28% 31
2016
Q4 		$3.46M Buy
213,333
+48,533
+29% +$888K 0.82% 40
2016
Q3 		$3.68M Buy
+164,800
New +$3.79M 1.18% 34

Other funds holding ALIM

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Armistice Capital's ALIM Position: Q1 2020 in Review

Armistice Capital sold out of Alimera Sciences (ALIM) in Q1 2020, closing a stake of 340,000 shares — an estimated $2.58M sold.

Armistice Capital first reported a position in ALIM in Q3 2016 and held it in 14 quarters. The position peaked at $9.06M in Q4 2017. 21 funds tracked by Wall St. Rank hold ALIM as of Q1 2020.

  • Armistice Capital reported no remaining Alimera Sciences position as of Q1 2020 after selling out during the quarter.
  • Armistice Capital sold 340,000 Alimera Sciences shares in Q1 2020, an estimated $2.58M.
  • Armistice Capital first reported a position in Alimera Sciences in Q3 2016 and held it in 14 quarters.
  • Armistice Capital's Alimera Sciences position peaked at $9.06M in Q4 2017.
  • 21 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2020.

Based on Armistice Capital's 13F filing for Q1 2020, filed 15 May 2020.